World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
68046
World Ranking
4636
National Ranking
2517

Myron Schwartz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Myron Schwartz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 603 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Myron Schwartz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Myron Schwartz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 114 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Myron Schwartz is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on medicine with an emphasis on hepatology, oncology, epidemiology, surgery, and cancer research. The scientist's work explores several main topics, including:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Pancreatic and Hepatic Oncology Research

Among the recent papers involving Myron Schwartz are:

  • Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference (2020) published in Hepatology
  • Intratumoral heterogeneity and clonal evolution in liver cancer (2020) published in Nature Communications
  • Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma (2023) published in Nature Medicine
  • Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) published in Nature Reviews Clinical Oncology
  • Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020) (2021) published in Gastroenterology

Myron Schwartz has collaborated frequently with several coauthors, including:

  • Parissa Tabrizian (34 publications)
  • Thomas U. Marron (28 publications)
  • Miriam Mérad (24 publications)
  • Josep M. Llovet (21 publications)
  • Maria Isabel Fiel (20 publications)

The scientist's publications have appeared repeatedly in journals such as:

  • Journal of Clinical Oncology (10 publications)
  • Gastroenterology (9 publications)
  • Journal of Hepatology (8 publications)
  • Regular and Young Investigator Award Abstracts (8 publications)
  • HPB (6 publications)

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix

  • Resection and liver transplantation for hepatocellular carcinoma.

    Josep M. Llovet;Myron Schwartz;Vincenzo Mazzaferro

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

    Jorge A. Marrero;Ziding Feng;Yinghui Wang;Mindie H. Nguyen

  • Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

    Augusto Villanueva;Derek Y. Chiang;Pippa Newell;Judit Peix

  • Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

    Daniela Sia;Yang Jiao;Iris Martinez-Quetglas;Olga Kuchuk;Olga Kuchuk

  • Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma

    Derek Y. Chiang;Augusto Villanueva;Yujin Hoshida;Yujin Hoshida;Judit Peix

  • Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

    Elisa Wurmbach;Ying Bei Chen;Greg Khitrov;Weijia Zhang

  • Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis

    Parissa Tabrizian;Ghalib Jibara;Brian Shrager;Myron Schwartz

  • A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma

    Sasan Roayaie;Iris N. Blume;Swan N. Thung;Maria Guido

  • The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

    Junko Ozao-Choy;Ge Ma;Johnny Kao;George X. Wang

  • Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

    Daniela Sia;Yujin Hoshida;Augusto Villanueva;Sasan Roayaie

  • Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

    Sasan Roayaie;Jason S. Frischer;Sukru H. Emre;Thomas M. Fishbein

  • Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline

    Lisa G. Newman;John Waller;Christopher J. Palestro;Myron Schwartz

  • Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.

    Sasan Roayaie;Jonathan D. Schwartz;Max W. Sung;Sukru H. Emre

  • Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.

    Augusto Villanueva;Augusto Villanueva;Yujin Hoshida;Yujin Hoshida;Carlo Battiston;Victoria Tovar;Victoria Tovar

  • A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis

    Josep M. Llovet;Yingbei Chen;Elisa Wurmbach;Sasan Roayaie

Frequent Co-Authors

Swan N. Thung
Swan N. Thung Icahn School of Medicine at Mount Sinai
Josep M. Llovet
Josep M. Llovet University of Barcelona
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Jordi Bruix
Jordi Bruix University of Barcelona
Yujin Hoshida
Yujin Hoshida The University of Texas Southwestern Medical Center
Scott L. Friedman
Scott L. Friedman Icahn School of Medicine at Mount Sinai
Lewis R. Roberts
Lewis R. Roberts Mayo Clinic
Wan Yee Lau
Wan Yee Lau Chinese University of Hong Kong
Samuel Waxman
Samuel Waxman Icahn School of Medicine at Mount Sinai
Steven H. Itzkowitz
Steven H. Itzkowitz Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can open doors to a diverse range of healthcare careers. Many students and working professionals seek alternative pathways beyond the traditional MD to quickly enter the healthcare workforce or expand their expertise. For those eager to start their careers sooner, an accelerated lpn program offers a fast-track to becoming a Licensed Practical Nurse, providing essential patient care in a variety of settings.

Mental health is an area of growing demand. If you’re interested in working as a nurse practitioner focused on psychiatry, consider the shortest pmhnp program available online. This option helps you earn specialization faster without compromising quality.

Not everyone in healthcare is directly involved with patient care—administrative roles are just as vital. Explore online healthcare administration programs to prepare for leadership and management positions in hospitals and clinics. If you’re looking for advanced study, discover the cheapest mha programs online healthcare to enhance your qualifications and career prospects affordably.

Best Scientists Citing Myron Schwartz

Trending Scientists

Recently Published Articles